Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer

Current Oncology

Volumn 21, Issue 3, 2014, Pages 441-448

  Mathews, M ^a   Ryan, D ^a   Gadag, V ^a   West, R ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Breast cancer; Cancer screening; Patient satisfaction; Prostate cancer; Wait times

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SELF EXAMINATION; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC TEST; DIGITAL RECTAL EXAMINATION; EDUCATION; EMPLOYMENT; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL MANAGEMENT; HUMAN; INCOME; MAJOR CLINICAL STUDY; MARRIAGE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; PATIENT SATISFACTION; PROSTATE CANCER; QUESTIONNAIRE; RURAL AREA; URBAN AREA; WAIT TIME;

EID: 84902688532     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.1843     Document Type: Article

References (19)

1. Crispo A, Barba M, D'Aituo G, et al. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series. BMC Cancer 2013;13:15.
2. Faria EF, Carvalhal GF, Vieira RA, et al. Comparison of clinical and pathologic fndings of prostate cancers detected through screening versus conventional referral in Brazil. Clin Genitourin Cancer 2011;9:104-108.
3. Hua L, Qiao D, Xu B, et al. Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China. Med Oncol 2011;28:357-364.
4. Kim J, Lee S, Bae S, et al. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes. Breast Cancer Res Treat 2012;131: 527-540.
5. Pande R, Froggatt P, Baragwanath P, Harmston C. Survival outcome of patients with screening vs. symptomatically detected colorectal cancers. Colorectal Dis 2012;15:74-79.
6. Pelzer AE, Colleselli D, Bektic, J, et al. Over-diagnosis and under-diagnosis of screen-vs. non-screen-detected prostate cancers within men with prostate-specific antigen levels of 2.0-10.0 ng/mL. BJU Int 2008;101:1223-1226.
7. Pelzer AE, Colleselli D, Bektic J, et al. Clinical and pathological features of screen vs. non-screen-detected prostate cancers: is there a difference? BJU Int 2008; 102: 2 4-27.
8. Redondo M, Funez R, Medina-Cano F, et al. Detection methods predict differences in biology and survival in breast cancer patients. BMC Cancer 2012;17:604.
9. Satoh H, Ishikawa H, Yamashita YT, et al. Outcome of patients with lung cancer detected by mass screening versus presentation with symptoms. Anticancer Res 1997;17: 2293-2296.
10. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013; 6: CD001877.
11. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev 2013;1:CD004720.
12. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007;:CD001216.
13. Mayo NE, Scott SC, Shen N, Hanley J, Goldberg MS, Mac-Donald N. Waiting time for breast cancer surgery in Quebec. CMAJ 2001;164:1133-1138.
14. Porter GA, Inglis KM, Wood LA, Veugelers PJ. Access to care and satisfaction in colorectal cancer patients. World J Surg 2005;29:1444-1451.
15. Hudson B, Zarifeh A, Young L, Wells JE. Patients' expectations of screening and preventive treatments. Ann Fam Med 2012;10:495-502.
16. Barratt A, Cockburn J, Furnival C, McBride A, Mallon L. Perceived sensitivity of mammographic screening: women's v iews on test accu racy and f nancial compensat ion for m issed cancers. J Epidemiol Community Health 1999;53:716-720.
17. Domenighetti G, D'Avanzo B, Egger M, et al. Women's perception of the benefts of mammography screening: population-based survey in four countries. Int J Epidemiol 2003;32:816-821.
18. Lostao L, Joiner TE, Pettit JW, Chorot P, Sandin B. Health beliefs and illness attitudes as predictors of breast cancer screening attendance. Eur J Public Health 2001;11:274-279.
19. Finney Rutten LI, Meissner HI, Breen N, Vernon SW, Rimer BK. Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey. Prev Med 2005;40:461-468.